LXEO
Lexeo Therapeutics, Inc.
$4.79
+0.19 (+4.13%)
At close · Jul 7
Market Cap
$376.12M
Shares
78,521,634
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-29 | 2026-06-25 | |
| 8-K | 2026-06-15 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-30 | 2025-12-31 | |
| 8-K | 2026-04-30 | 2026-04-28 | |
| 10-K | 2026-03-30 | 2025-12-31 | |
| 8-K | 2026-03-30 | — | |
| 8-K | 2026-02-05 | 2026-01-30 | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-17 | 2025-10-16 | |
| 8-K | 2025-10-07 | — | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-05-27 | — | |
| 10-Q/A | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | 2024-12-31 | |
| 8-K | 2025-04-07 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-19 | 2024-12-18 | |
| 8-K | 2024-11-13 | 2024-11-11 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 8-K | 2024-10-09 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-07-15 | — | |
| 8-K | 2024-07-08 | — | |
| 8-K | 2024-06-28 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-26 | 2023-12-31 | |
| 8-K | 2024-04-22 | — | |
| 8-K | 2024-04-22 | — | |
| 8-K | 2024-04-16 | — | |
| 8-K | 2024-03-11 | — | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-02-05 | — | |
| 8-K | 2023-12-18 | — | |
| 8-K | 2023-12-11 | — | |
| 10-Q | 2023-12-11 | 2023-09-30 | |
| 8-K | 2023-11-07 | — |
Showing 1–50 of 50 filings